Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Med27em1flox/Cya
Common Name:
Med27-flox
Product ID:
S-CKO-14371
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Med27-flox
Strain ID
CKOCMP-68975-Med27-B6J-VA
Gene Name
Med27
Product ID
S-CKO-14371
Gene Alias
1500015J03Rik; 2310042P07Rik; Crsp8; D2Ertd434e
Background
C57BL/6JCya
NCBI ID
68975
Modification
Conditional knockout
Chromosome
2
Phenotype
MGI:1916225
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Med27em1flox/Cya mice (Catalog S-CKO-14371) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000028139
NCBI RefSeq
NM_026896
Target Region
Exon 3
Size of Effective Region
~1.0 kb
Detailed Document
Click here to download >>
Overview of Gene Research
MED27 is a subunit of the Mediator multiprotein complex, which is involved in transcriptional regulation [1,3]. The Mediator complex usually cooperates with transcription factors to participate in RNA polymerase II-mediated gene transcription [2]. Genetic models, such as gene knockout mouse models, can be used to study the function of MED27.

In cardiac development, ablation of MED27 in developing mouse cardiomyocytes leads to embryonic lethality, while its deletion in adult cardiomyocytes causes heart failure and mortality. This reveals that MED27 is essential for cardiac development and function by maintaining the stability of the Mediator core [6].

In breast cancer, MED27 knockdown in triple-negative breast cancer cells inhibits cancer cell metastasis and stemness maintenance, and also sensitizes breast cancer cells to epirubicin treatment. Mechanistically, MED27 transcriptionally regulates KLF4 by binding to its promoter region [2].

In melanoma, silencing of MED27 leads to melanoma cell proliferation inhibition, cell cycle arrest, and apoptosis induction, along with inactivation of PI3K/AKT and MAPK/ERK signaling and activation of the apoptotic pathway [4].

In adrenal cortical carcinoma, down-regulation of MED27 induces cell apoptosis and attenuates cell proliferation, invasion, and metastasis, regulating the expression of EMT-related proteins and Wnt/β-catenin signaling pathway-related proteins [5].

In neurodevelopmental disorders, biallelic MED27 variants lead to a broad phenotypic continuum from developmental and epileptic-dyskinetic encephalopathy to variable neurodevelopmental disorder with movement abnormalities. Features include global developmental delay/intellectual disability, bilateral cataracts, infantile hypotonia, microcephaly, gait ataxia, dystonia, and more. Brain MRI shows cerebellar atrophy, white matter volume loss, pontine hypoplasia, etc. [1,3].

In conclusion, MED27 is crucial for maintaining the stability of the Mediator complex, thus playing essential roles in cardiac development and function. In diseases, it promotes the progression of certain cancers like breast cancer, melanoma, and adrenal cortical carcinoma, and is associated with neurodevelopmental disorders. The study of MED27 using gene knockout models has provided valuable insights into its functions in these biological processes and disease conditions.

References:
1. Maroofian, Reza, Kaiyrzhanov, Rauan, Cali, Elisa, Houlden, Henry, Severino, Mariasavina. . Biallelic MED27 variants lead to variable ponto-cerebello-lental degeneration with movement disorders. In Brain : a journal of neurology, 146, 5031-5043. doi:10.1093/brain/awad257. https://pubmed.ncbi.nlm.nih.gov/37517035/
2. Wang, Ruozhu, Yu, Wendan, Zhu, Tianhua, Xu, Lingzhi, Deng, Wuguo. 2023. MED27 plays a tumor-promoting role in breast cancer progression by targeting KLF4. In Cancer science, 114, 2277-2292. doi:10.1111/cas.15757. https://pubmed.ncbi.nlm.nih.gov/36786527/
3. Meng, Linyan, Isohanni, Pirjo, Shao, Yunru, Carroll, Christopher J, Yang, Yaping. 2021. MED27 Variants Cause Developmental Delay, Dystonia, and Cerebellar Hypoplasia. In Annals of neurology, 89, 828-833. doi:10.1002/ana.26019. https://pubmed.ncbi.nlm.nih.gov/33443317/
4. Tang, Ranran, Xu, Xiangdong, Yang, Wenjing, Li, Man, Deng, Wuguo. 2016. MED27 promotes melanoma growth by targeting AKT/MAPK and NF-κB/iNOS signaling pathways. In Cancer letters, 373, 77-87. doi:10.1016/j.canlet.2016.01.005. https://pubmed.ncbi.nlm.nih.gov/26797421/
5. He, Hongchao, Dai, Jun, Yang, Xiaoqun, Sun, Fukang, Zhu, Yu. . Silencing of MED27 inhibits adrenal cortical carcinogenesis by targeting the Wnt/β-catenin signaling pathway and the epithelial-mesenchymal transition process. In Biological chemistry, 399, 593-602. doi:10.1515/hsz-2017-0304. https://pubmed.ncbi.nlm.nih.gov/29730647/
6. Zhu, Siting, Chen, Ze'e, Liu, Canzhao, Fang, Xi, Ouyang, Kunfu. 2024. The essential role of MED27 in stabilizing the mediator complex for cardiac development and function. In Life sciences, 356, 123020. doi:10.1016/j.lfs.2024.123020. https://pubmed.ncbi.nlm.nih.gov/39209248/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest